BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21733992)

  • 1. Autocrine proliferative effects of hGH are maintained in primary cultures of human mammary carcinoma cells.
    Chiesa J; Ferrer C; Arnould C; Vouyovitch CM; Diaz JJ; Gonzalez S; Mares P; Morel G; Wu ZS; Zhu T; Lobie PE; Mertani HC
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1418-26. PubMed ID: 21733992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
    Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
    Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.
    Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent.
    Kaulsay KK; Mertani HC; Lee KO; Lobie PE
    Endocrinology; 2000 Apr; 141(4):1571-84. PubMed ID: 10746665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of autocrine/paracrine effects of human growth hormone in human mammary carcinoma cells.
    Vouyovitch CM; Vidal L; Borges S; Raccurt M; Arnould C; Chiesa J; Lobie PE; Lachuer J; Mertani HC
    Adv Exp Med Biol; 2008; 617():493-500. PubMed ID: 18497074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
    Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone.
    Kaulsay KK; Mertani HC; Törnell J; Morel G; Lee KO; Lobie PE
    Exp Cell Res; 1999 Jul; 250(1):35-50. PubMed ID: 10388519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor.
    Kaulsay KK; Zhu T; Bennett W; Lee KO; Lobie PE
    Endocrinology; 2001 Feb; 142(2):767-77. PubMed ID: 11159849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells.
    Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK
    Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells.
    Chen YJ; Zhang X; Wu ZS; Wang JJ; Lau AY; Zhu T; Lobie PE
    Cancer Lett; 2015 Sep; 365(2):182-9. PubMed ID: 26070963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
    Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
    Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.
    Mukhina S; Mertani HC; Guo K; Lee KO; Gluckman PD; Lobie PE
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15166-71. PubMed ID: 15353581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone.
    Zhu T; Starling-Emerald B; Zhang X; Lee KO; Gluckman PD; Mertani HC; Lobie PE
    Cancer Res; 2005 Jan; 65(1):317-24. PubMed ID: 15665309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
    Pandey V; Perry JK; Mohankumar KM; Kong XJ; Liu SM; Wu ZS; Mitchell MD; Zhu T; Lobie PE
    Endocrinology; 2008 Aug; 149(8):3909-19. PubMed ID: 18450952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C.
    Bougen NM; Yang T; Chen H; Lobie PE; Perry JK
    Oncol Rep; 2011 Aug; 26(2):487-93. PubMed ID: 21567106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymically-modified human mammary carcinoma cells: modulators of macrophage functions.
    Hakim AA
    Cancer Biochem Biophys; 1979; 3(2):85-92. PubMed ID: 121921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis.
    Zhu Z; Mukhina S; Zhu T; Mertani HC; Lee KO; Lobie PE
    Oncogene; 2005 May; 24(23):3774-85. PubMed ID: 15782123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT4 mediates the autocrine effects of growth hormone in mammary carcinoma cells.
    Vouyovitch CM; Perry JK; Liu DX; Bezin L; Vilain E; Diaz JJ; Lobie PE; Mertani HC
    Endocr Relat Cancer; 2016 Jul; 23(7):571-85. PubMed ID: 27323961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival.
    Mertani HC; Zhu T; Goh EL; Lee KO; Morel G; Lobie PE
    J Biol Chem; 2001 Jun; 276(24):21464-75. PubMed ID: 11297545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland.
    Raccurt M; Lobie PE; Moudilou E; Garcia-Caballero T; Frappart L; Morel G; Mertani HC
    J Endocrinol; 2002 Nov; 175(2):307-18. PubMed ID: 12429029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.